KR102594005B1 - Cosmetic composition comprising cannabis liposome - Google Patents
Cosmetic composition comprising cannabis liposome Download PDFInfo
- Publication number
- KR102594005B1 KR102594005B1 KR1020230035208A KR20230035208A KR102594005B1 KR 102594005 B1 KR102594005 B1 KR 102594005B1 KR 1020230035208 A KR1020230035208 A KR 1020230035208A KR 20230035208 A KR20230035208 A KR 20230035208A KR 102594005 B1 KR102594005 B1 KR 102594005B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- hemp
- conditioning agent
- skin conditioning
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 239000002537 cosmetic Substances 0.000 title claims abstract description 31
- 239000002502 liposome Substances 0.000 title claims description 33
- 240000004308 marijuana Species 0.000 title 1
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 89
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims abstract description 86
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims abstract description 86
- 235000009120 camo Nutrition 0.000 claims abstract description 86
- 235000005607 chanvre indien Nutrition 0.000 claims abstract description 86
- 239000011487 hemp Substances 0.000 claims abstract description 86
- 238000000855 fermentation Methods 0.000 claims abstract description 15
- 230000004151 fermentation Effects 0.000 claims abstract description 15
- 239000010460 hemp oil Substances 0.000 claims abstract description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 34
- 230000003750 conditioning effect Effects 0.000 claims description 34
- 239000003921 oil Substances 0.000 claims description 16
- 235000019198 oils Nutrition 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 12
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 12
- 239000004094 surface-active agent Substances 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 9
- 239000000839 emulsion Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 235000020238 sunflower seed Nutrition 0.000 claims description 7
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 6
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 6
- VYZKQGGPNIFCLD-UHFFFAOYSA-N 3,3-dimethylhexane-2,2-diol Chemical compound CCCC(C)(C)C(C)(O)O VYZKQGGPNIFCLD-UHFFFAOYSA-N 0.000 claims description 6
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 6
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- RGMZNZABJYWAEC-UHFFFAOYSA-N Methyltris(trimethylsiloxy)silane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C RGMZNZABJYWAEC-UHFFFAOYSA-N 0.000 claims description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 6
- 229960005305 adenosine Drugs 0.000 claims description 6
- 229960000458 allantoin Drugs 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- WNLRTRBMVRJNCN-UHFFFAOYSA-N hexanedioic acid Natural products OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 6
- 229940073663 methyl trimethicone Drugs 0.000 claims description 6
- 235000005152 nicotinamide Nutrition 0.000 claims description 6
- 229960003966 nicotinamide Drugs 0.000 claims description 6
- 239000011570 nicotinamide Substances 0.000 claims description 6
- 229960001295 tocopherol Drugs 0.000 claims description 6
- 229930003799 tocopherol Natural products 0.000 claims description 6
- 235000010384 tocopherol Nutrition 0.000 claims description 6
- 239000011732 tocopherol Substances 0.000 claims description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 6
- 239000004909 Moisturizer Substances 0.000 claims description 5
- 239000001361 adipic acid Substances 0.000 claims description 5
- 235000011037 adipic acid Nutrition 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 5
- 230000001333 moisturizer Effects 0.000 claims description 5
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 4
- 235000011402 Rosa x damascena Nutrition 0.000 claims description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 3
- 244000044822 Simmondsia californica Species 0.000 claims description 3
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 3
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 229930182478 glucoside Natural products 0.000 claims description 3
- 150000008131 glucosides Chemical class 0.000 claims description 3
- 229940075529 glyceryl stearate Drugs 0.000 claims description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 2
- 229920006037 cross link polymer Polymers 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 244000181025 Rosa gallica Species 0.000 claims 2
- 239000003906 humectant Substances 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- 241000218236 Cannabis Species 0.000 abstract description 16
- 239000004480 active ingredient Substances 0.000 abstract description 10
- 238000005516 engineering process Methods 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 27
- 238000000034 method Methods 0.000 description 20
- 230000008569 process Effects 0.000 description 16
- -1 terpene compounds Chemical class 0.000 description 15
- 239000004615 ingredient Substances 0.000 description 13
- 238000009472 formulation Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000006071 cream Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000000344 soap Substances 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000002421 anti-septic effect Effects 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000007586 terpenes Nutrition 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 150000003505 terpenes Chemical class 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- 235000008697 Cannabis sativa Nutrition 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 2
- IXCUTZUASDSIJO-UHFFFAOYSA-N 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-(3-methylbut-2-enyl)chromen-4-one Chemical compound C1=C(O)C(OC)=CC(C=2OC3=CC(O)=C(CC=C(C)C)C(O)=C3C(=O)C=2)=C1 IXCUTZUASDSIJO-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 240000004978 Rosa x damascena Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 229930003827 cannabinoid Natural products 0.000 description 2
- 239000003557 cannabinoid Substances 0.000 description 2
- 229940065144 cannabinoids Drugs 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 229960004242 dronabinol Drugs 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000218235 Cannabaceae Species 0.000 description 1
- MWGFICMOCSIQMV-LZYBPNLTSA-N Cannflavin A Chemical compound C1=C(O)C(OC)=CC(C=2OC3=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C3C(=O)C=2)=C1 MWGFICMOCSIQMV-LZYBPNLTSA-N 0.000 description 1
- MWGFICMOCSIQMV-PXNMLYILSA-N Cannflavin A Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)c(C/C=C(\CC/C=C(\C)/C)/C)c(O)c3)C(=O)C=2)c1 MWGFICMOCSIQMV-PXNMLYILSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 210000005091 airway smooth muscle Anatomy 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 1
- 229950011318 cannabidiol Drugs 0.000 description 1
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 대마의 뿌리, 줄기 및 씨를 모두 활용한 화장품 조성물에 관한 것으로서 뿌리, 줄기 및 씨 각 부분의 유효성분을 최적으로 활용하기 위한 기술에 관한 것이다. 특히 본 발명은 대마뿌리 추출물, 대마줄기 추출물, 대마뿌리 발효 추출물 및 대마씨 오일을 포함하는 대마 복합물을 리포좀화하여 화장품 조성물에 함유시키는 것을 특징으로 한다. The present invention relates to a cosmetic composition using all of the roots, stems, and seeds of cannabis, and to technology for optimally utilizing the active ingredients of each part of the roots, stems, and seeds. In particular, the present invention is characterized in that a hemp complex containing hemp root extract, hemp stem extract, hemp root fermentation extract, and hemp seed oil is liposomed and contained in a cosmetic composition.
Description
본 발명은 대마의 뿌리, 줄기 및 씨를 모두 활용한 화장품 조성물에 관한 것으로서 뿌리, 줄기 및 씨 각 부분의 유효성분을 최적으로 활용하기 위한 기술에 관한 것이다. 특히 본 발명은 대마뿌리 추출물, 대마줄기 추출물, 대마뿌리 발효 추출물 및 대마씨 오일을 포함하는 대마 복합물을 리포좀화하여 화장품 조성물에 함유시키는 것을 특징으로 한다. The present invention relates to a cosmetic composition using all of the roots, stems, and seeds of cannabis, and to technology for optimally utilizing the active ingredients of each part of the roots, stems, and seeds. In particular, the present invention is characterized in that a hemp complex containing hemp root extract, hemp stem extract, hemp root fermentation extract, and hemp seed oil is liposomed and contained in a cosmetic composition.
대마 (Cannabis sativa L.)는 삼과에 속하는 한해살이풀이다. 원산지는 중앙아시아로 캐나다, 미국, 유럽 등 전 세계적으로 다양한 기후와 지역조건에 잘 적응하여 여러 품종으로 재배되고 있다. 대마 품종에는 일반적으로 여러 칸나비노이드를 함유하고 있으며 테르펜, 플라보노이드, 피토스테롤과 같은 다양한 2차 대사산물의 공급원이다.(비특허문헌 1) Hemp ( Cannabis sativa L. ) is an annual herb belonging to the Hemp family. Its origin is Central Asia, and it is cultivated in various varieties around the world, including in Canada, the United States, and Europe, adapting well to various climates and regional conditions. Hemp varieties generally contain several cannabinoids and are a source of various secondary metabolites such as terpenes, flavonoids, and phytosterols (Non-patent Document 1).
살펴보면, 대마씨에서 얻은 식물성 기름에서는 포도씨유, 콩기름, 해바라기씨유 등 다양한 식물성 기름과 비교했을 때 페놀화합물의 함량이 가장 높고 항산화능도 월등히 높은 것으로 나타났으며, 대마의 부위에 따라 다양한 플라보노이드와 플라본, 리그난 등을 함유하고 있다. 그 중에서도 대마에서만 발견된 플라보노이드의 일종인 칸플라빈 A (Cannflavin A)와 칸플라빈 B (Cannflavin B)의 경우 항산화능이 뛰어난 것으로 밝혀졌다. 대마의 향과 맛을 내는 역할을 하는 테르펜 계열의 화합물 역시 대마에서 100여 개 이상 밝혀졌고, 다양한 모노테르페노이드(monoterpenoids)와 세스키테르페노이드(sesquiterpenoids) 등의 형태로 존재한다. 테르펜은 항암, 항염증 작용 등 다양한 약리작용과 관련이 있는 것으로 밝혀졌으나 아직까지 대마에서 추출된 테르펜 화합물들의 연구는 THC(테트라하이드로칸나비놀, tetrahydrocannabinol)에 비해 미비한 실정이다.When compared to various vegetable oils such as grape seed oil, soybean oil, and sunflower seed oil, the vegetable oil obtained from hemp seeds was found to have the highest content of phenolic compounds and a much higher antioxidant capacity. Depending on the part of the hemp, various flavonoids and Contains flavones, lignans, etc. Among them, Cannflavin A and Cannflavin B, a type of flavonoid found only in hemp, were found to have excellent antioxidant properties. More than 100 terpene-based compounds, which play a role in producing the aroma and taste of cannabis, have also been identified in cannabis, and exist in the form of various monoterpenoids and sesquiterpenoids. Terpenes have been found to be related to various pharmacological effects such as anti-cancer and anti-inflammatory effects, but research on terpene compounds extracted from hemp is still insufficient compared to THC (tetrahydrocannabinol).
그러나 대마의 주성분인 칸나비노이드, 테르펜 및 플라보노이드 등 대부분 성분은 지질친화성을 가진 물질들이므로 물에 잘 용해되지 않기 때문에 생체 이용율을 높이기 위한 다양한 방법이 강구되고 있다. However , most of the main components of cannabis, such as cannabinoids, terpenes, and flavonoids, are lipophilic substances and do not dissolve well in water, so various methods are being explored to increase bioavailability.
난용성 활성성분은 물 또는 다른 용매에 잘 녹지 않는 활성성분을 의미하며, 난용성으로 인해 그 실용성이 제한되는 경우가 많다. 예를 들어, 신약으로 개발되는 약물 중 약 41% 이상이 난용성으로 인하여 중도에 포기되고 있으며, 미국 약전(US Pharmacopeia)에 등재된 약물의 약 ⅓이상이 난용성 약물로 분류되고 있다.Poorly soluble active ingredients refer to active ingredients that do not dissolve well in water or other solvents, and their practicality is often limited due to their poor solubility. For example, more than 41% of drugs being developed as new drugs are abandoned due to poor solubility, and more than ⅓ of the drugs listed in the US Pharmacopeia are classified as poorly soluble drugs.
이러한 난용성 활성성분을 사용하기 위해서는 난용성을 해결하기 위한 부가적인 물질이 첨가되어야 하나, 부가되는 물질의 독성으로 인하여 사용이 제한되는 사례가 다수 보고되고 있다.In order to use these poorly soluble active ingredients, additional substances must be added to resolve the poor solubility, but many cases have been reported in which use is restricted due to the toxicity of the added substances.
대마 줄기는 셀룰로오스 함량이 높아 옷감, 제지 산업에서 섬유를 생산하는 데 사용된다. 대마 폐기물은 바이오 연료와 시멘트 원료로 사용된다. 대마씨는 필수 아미노산, 단백질, 고도불포화 지방산을 함유하고 있어 식품 및 영양 보조제로 사용된다. 대마씨 오일에는 생물학적 활성을 갖는 리그난아미드 및 폴리페놀 화합물을 함유하고 있다. 대마 뿌리는 전통 의학에서 염증, 관절 통증, 통풍 및 기타 병리학적 상태를 치료하기 위해 처방되어 왔다. 대마 종의 꽃이나 잎에 비해 뿌리의 약리학에 대한 연구는 상대적으로 적었지만, 최근 뿌리의 약리 활성에 대한 연구가 증가하고 있다.Hemp stems have a high cellulose content and are used to produce fibers in the textile and paper industries. Hemp waste is used as biofuel and cement raw material. Hemp seeds contain essential amino acids, proteins, and polyunsaturated fatty acids and are used as food and nutritional supplements. Hemp seed oil contains lignanamides and polyphenol compounds that have biological activity. Hemp root has been prescribed in traditional medicine to treat inflammation, joint pain, gout and other pathological conditions. There has been relatively little research on the pharmacology of the roots of cannabis species compared to the flowers or leaves, but research on the pharmacological activity of the roots has recently been increasing.
Lima 외 연구진은 시험관 내, 생체 외 및 생체 내 마우스에서 대마 뿌리의 물 추출물로 단일 투여 및 반복 투여하여 독성과 항염증 및 진경제 효과를 평가했다.(비특허문헌 2) 그 결과는 기도 평활근에 경련 효과가 없고 마우스에서 현저한 독성이 없는 대마 뿌리 추출물의 항염 효과를 보여주었다. 또한 Menezes 외 연구진은 수컷 마우스를 사용한 동물 연구에서 대마 뿌리의 물 추출물이 기침을 치료하고 체액 가래를 촉진할 가능성이 있다고 제안했다.(비특허문헌 3)Lima et al. evaluated the toxicity, anti-inflammatory and antispasmodic effects of single and repeated administrations of water extract of cannabis root in mice in vitro, ex vivo and in vivo (Non-Patent Document 2). The results showed that spasms in airway smooth muscles were observed. showed an anti-inflammatory effect of cannabis root extract with no effect and no significant toxicity in mice. Additionally, Menezes et al., in an animal study using male mice, suggested that a water extract of cannabis root has the potential to treat cough and promote phlegm production (Non-patent Document 3).
본 발명은 대마의 뿌리, 줄기 및 씨를 모두 활용한 화장품 조성물에 관한 것으로서 뿌리, 줄기 및 씨 각 부분의 유효성분을 최적으로 활용하기 위한 아이디어에 기반한다. 특히 본 발명은 대마뿌리 추출물, 대마줄기 추출물, 대마뿌리 발효 추출물 및 대마씨 오일을 포함하는 대마 복합물을 리포좀화하여 화장품 조성물에 포함시키는 것을 특징으로 한다. The present invention relates to a cosmetic composition using all of the roots, stems, and seeds of cannabis, and is based on the idea of optimally utilizing the active ingredients of each part of the roots, stems, and seeds. In particular, the present invention is characterized in that a hemp complex containing hemp root extract, hemp stem extract, hemp root fermentation extract, and hemp seed oil is liposomed and included in a cosmetic composition.
선행특허문헌을 살펴보면, (특허문헌 1)에는, 대마추출물을 함유하는 피부 미백 및 주름 개선용 화장료 조성물이 기재되어 있다. 여기에서의 대마추출물은 대마씨앗 껍질을 벗겨낸 후 오일로 추출되는 것으로 기재되어 있다. (특허문헌 2)에는, 대마 줄기 추출물을 유효성분으로 포함하는 항노화, 항염 또는 피부재생용 조성물이 기재되어 있다. (특허문헌 3)에는, 칸나비디올 또는 그 유도체를 함유하는 아토피 개선용 화장료 조성물이 기재되어 있다. Looking at prior patent documents, (Patent Document 1) describes a cosmetic composition for skin whitening and wrinkle improvement containing hemp extract. The hemp extract here is described as being extracted as oil after peeling the hemp seeds. (Patent Document 2) describes a composition for anti-aging, anti-inflammatory or skin regeneration containing hemp stem extract as an active ingredient. (Patent Document 3) describes a cosmetic composition for improving atopic dermatitis containing cannabidiol or a derivative thereof.
해결과제 1은, 대마의 뿌리, 줄기 및 씨를 모두 활용한 화장품 조성물을 제공하는 것이다. 해결과제 2는, 대마의 뿌리, 줄기 및 씨 각 부분의 유효성분을 최적으로 포함한 화장품 조성물을 제공하는 것이다. 해결과제 3은, 화장품 조성물 제조공정에서 대마 성분의 난용성 문제를 해결하고 대마 성분을 피부 내층으로 최적으로 침투시키기 위하여, 대마 유효성분을 리포좀화하는 공정을 이용한 화장품 조성물을 제공하는 것이다.Problem 1 is to provide a cosmetic composition that utilizes all of the roots, stems, and seeds of hemp. Problem 2 is to provide a cosmetic composition that optimally contains the active ingredients of each part of the root, stem, and seed of cannabis. Problem 3 is to provide a cosmetic composition using a process of liposomeizing hemp active ingredients in order to solve the problem of poor solubility of hemp ingredients in the cosmetic composition manufacturing process and optimally penetrate the hemp ingredients into the inner layer of the skin.
해결수단 1은, 대마뿌리 추출물, 대마줄기 추출물, 대마뿌리 발효 추출물 및 대마씨 오일을 포함하는 대마 복합물을 리포좀화한 리포좀을 함유하는 화장품 조성물이다.Solution 1 is a cosmetic composition containing liposomes obtained by liposomeizing a hemp complex containing hemp root extract, hemp stem extract, hemp root fermentation extract, and hemp seed oil.
해결수단 2는, 해결수단 1에서, 상기 대마 복합물은,Solution 2: In solution 1, the hemp complex is,
대마뿌리 추출물 0.001~20 중량부, 대마줄기 추출물 0.001 내지 20 중량부, 대마뿌리 발효 추출물 0.001 내지 20 중량부 및 대마씨오일 0.001 내지 20 중량부를 포함하는 것을 특징으로 하는, 화장품 조성물이다.A cosmetic composition comprising 0.001 to 20 parts by weight of hemp root extract, 0.001 to 20 parts by weight of hemp stem extract, 0.001 to 20 parts by weight of hemp root fermentation extract, and 0.001 to 20 parts by weight of hemp seed oil.
해결수단 3은, 해결수단 1 또는 2에서, 상기 리포좀은,Solution 3 is that in solution 1 or 2, the liposome is,
하이드롤라이즈드콜라겐추출물, 글리세린, 나이아신아마이드, 알란토인, 아데노신, 부틸렌글라이콜, 하이드로제네이티드레시틴, 메틸트라이메티콘, 해바라기씨오일, 글리세레스-25피씨에이아이소스테아레이트, 트라이메틸펜탄다이올/아디픽애씨드코폴리머 및 토코페롤이 추가로 포함되어 리포좀화된 것을 특징으로 하는, 화장품 조성물이다.Hydrolyzed collagen extract, glycerin, niacinamide, allantoin, adenosine, butylene glycol, hydrogenated lecithin, methyl trimethicone, sunflower seed oil, glycerol-25PCA isostearate, trimethylpentanediol /Adipic acid copolymer and tocopherol are additionally included and are liposomal.
해결수단 4는, 해결수단 1 또는 2에서, 상기 리포좀은,Solution 4 is that in solution 1 or 2, the liposome is,
하이드롤라이즈드콜라겐추출물, 글리세린, 나이아신아마이드, 알란토인, 아데노신, 하이드로제네이티드레시틴, 메틸트라이메티콘, 해바라기씨오일, 글리세레스-25피씨에이아이소스테아레이트, 트라이메틸펜탄다이올/아디픽애씨드코폴리머, 토코페롤, 폴리글리세릴-3메틸글루코오스다이스테아레이트, 폴리글리세릴-2스테아레이트, 글리세릴스테아레이트, 스테아릴알코올, 호호바씨오일, 세테아릴글루코사이드, 솔비탄올리베이트 및 세테아릴알코올이 추가로 포함되어 리포좀된한 것을 특징으로 하는, 화장품 조성물이다.Hydrolyzed collagen extract, glycerin, niacinamide, allantoin, adenosine, hydrogenated lecithin, methyl trimethicone, sunflower seed oil, glycerol-25PCA isostearate, trimethylpentanediol/adipic acid co. Polymer, tocopherol, polyglyceryl-3methylglucose distearate, polyglyceryl-2stearate, glyceryl stearate, stearyl alcohol, jojoba seed oil, cetearyl glucoside, sorbitan olivate and cetearyl alcohol. It is a cosmetic composition, which is further characterized in that it contains liposomes.
해결수단 5는, 해결수단 1 또는 2에 있어서,Solution 5 is in solution 1 or 2,
방부제 및 향을 추가로 포함시키는 특징으로 하는, 화장품 조성물이다.It is a cosmetic composition characterized by additionally containing a preservative and fragrance.
발명의 효과는, 1. 대마 뿌리, 줄기 및 씨의 유효성분을 최적으로 활용할 수 있다는 점, 2. 대마의 난용성 성분을 리포좀화하여 피부 내측으로 전달하여 피부에 적극적인 효과를 발휘할 수 있다는 점이다.The effectiveness of the invention is that 1. the active ingredients of cannabis roots, stems, and seeds can be optimally utilized; 2. the poorly soluble components of cannabis can be liposomed and delivered to the inside of the skin to exert an active effect on the skin. .
본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정하여 해석되어서는 아니되며, 발명자가 발명의 용어와 개념을 가장 최선의 방법으로 설명하기 위하여 본 발명의 기술적 사상에 부합하는 의미와 개념에 입각하여 기재한 것으로 해석하여야 한다.Terms or words used in this specification and claims should not be construed as limited to their ordinary or dictionary meanings, and the inventor should use the terms and concepts of the invention in the best possible way to explain them in accordance with the technical idea of the invention. It must be interpreted as written based on meaning and concept.
따라서, 본 발명은 제시되는 제조예, 실험예 및 실시예에 한정되지 않으며, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의하여 본 발명의 기술 사상과 아래에 기재될 특허청구범위에 기재된 기술사상의 균등한 범위 내에서 다양한 수정 및 변경이 가능하다.Therefore, the present invention is not limited to the presented manufacturing examples, experimental examples, and examples, and the technical idea of the present invention and the patent claims described below can be understood by those skilled in the art to which the present invention pertains. Various modifications and changes are possible within the scope of technical philosophy.
본 발명은 첨부된 도면을 참조하여 바람직한 제조예, 실험예 및 실시예를 중심으로 기술되었지만 당업자라면 이러한 기재로부터 기술적 범주를 벗어남이 없이 다양한 변형이 가능하다는 것은 명백하다. 따라서 본 발명의 범주는 이러한 많은 변형예들을 포함할 수 있다.The present invention has been described focusing on preferred manufacturing examples, experimental examples, and examples with reference to the attached drawings, but it is clear to those skilled in the art that various modifications can be made without departing from the technical scope of these descriptions. Accordingly, the scope of the present invention may include many such variations.
실시예1. 대마 복합물 리포좀을 함유하는 화장품 조성물Example 1. Cosmetic composition containing hemp complex liposomes
대마 복합물 리포좀을 함유하는 화장품 조성물을 제공한다. 대마 복합물은 대마뿌리 추출물, 대마줄기 추출물, 대마뿌리 발효 추출물 및 대마씨 오일을 포함하고, 이렇게 제조된 대마 복합물을 리포좀화하여 화장품 조성물에 함유시킨다.A cosmetic composition containing hemp complex liposomes is provided. The hemp complex includes hemp root extract, hemp stem extract, hemp root fermentation extract, and hemp seed oil, and the hemp complex thus prepared is liposomed and included in a cosmetic composition.
조성물의 제조방법을 단계별로 살펴보면 다음과 같다.The manufacturing method of the composition is looked at step by step as follows.
1 단계) 대마 뿌리, 줄기를 각각 추출하여 대마뿌리 추출물 및 대마줄기 추출물을 제조한다. 바람직하게, 알코올 용매를 이용하여 추출하며 조건에 따라서는 이산화탄소 가압 추출기법이나 초임계 기법 등을 추가적으로 이용할 수도 있다. Step 1) Extract the hemp roots and stems respectively to prepare hemp root extract and hemp stem extract. Preferably, extraction is performed using an alcohol solvent, and depending on conditions, a carbon dioxide pressurized extraction technique or a supercritical technique may be additionally used.
2 단계) 대마 뿌리를 바실러스 균주를 이용하여 발효하여 성분을 전환시킨 대마뿌리 발효 추출물을 제조한다. 바람직하게, 락토바실러스 균주를 이용하고 통상적인 발효 기법을 이용한다. Step 2) Fermentation of hemp roots using Bacillus strains produces a hemp root fermentation extract with converted ingredients. Preferably, Lactobacillus strains are used and conventional fermentation techniques are used.
3 단계) 대마씨 오일을 제조한다. 바람직하게, 대마씨를 압착하여 오일을 추출한다.Step 3) Prepare hemp seed oil. Preferably, hemp seeds are pressed to extract the oil.
4 단계) 대마뿌리 추출물, 대마줄기 추출물, 대마뿌리 발효 추출물 및 대마씨 오일을 리포좀화한다. Step 4) Liposome the hemp root extract, hemp stem extract, hemp root fermentation extract, and hemp seed oil.
리포좀은 인지질을 섞은 용액에 초음파를 주거나 필터를 기계적인 힘으로 통과시켜 인공적으로 만들 수 있다. 리포좀은 인지질과 만드는 방법에 따라 다양하게 만들 수 있으며 구조적으로 신축성을 띤다. 리포좀은 생체막을 이루는 인지질로 이루어져 있어 생체 적합성과 분해성 그리고 안정성이 뛰어나다. 또한 세포막과 같은 인지질로 이루어져 있으므로 실제 세포의 세포막을 연구하는 모델로도 사용되고 있다. 리포좀에 넣어 전달할 수 있는 물질로는 항암제, 조영제, 항진균제, 항세균제, 면역조절물질, 항원 및 항체, 헤모글로빈, 단백질, 지방, DNA등이 있으며 실제 임상에서도 널리 쓰이고 있다. 리포좀의 크기는 대략 수십 나노미터에서 수 마이크로에 이른다. 1965년 부터 시작된 리포좀에 관련된 연구는 매우 많지만 대부분 리포좀 군집의 성격을 설명하고 있다. Liposomes can be artificially created by applying ultrasound to a solution mixed with phospholipids or passing them through a filter with mechanical force. Liposomes can be made in various ways depending on the phospholipid and manufacturing method, and are structurally flexible. Liposomes are made up of phospholipids that form biological membranes, so they have excellent biocompatibility, degradability, and stability. Additionally, since it is made of phospholipids like cell membranes, it is also used as a model to study cell membranes of actual cells. Substances that can be delivered in liposomes include anticancer agents, contrast agents, antifungal agents, antibacterial agents, immunomodulators, antigens and antibodies, hemoglobin, proteins, fats, and DNA, and are widely used in actual clinical practice. The size of liposomes ranges from approximately tens of nanometers to several microns. There are many studies related to liposomes that began in 1965, but most of them explain the characteristics of liposome populations.
최근에는 나노기술의 발달에 힘입어 개별적인 리포좀의 성질 또는 조절 등의 연구가 활발하게 진행되고 있다. 리포좀은 약품 전달 매체로서 대량생산과 품질관리가 용이하고 다양한 경로로 투여할 수 있고 면역반응이 없으므로 반복 투여가 가능하며 구조 및 성분 변경이 쉽기 때문에 개발의 여지가 무궁 무진하다. 또한 나노기술에서 미세가공 툴로서 주목을 받는 자기조립 (Self-assembly: 분자들이 제각각 인위적인 조작 없이 자발적으로 개개의 구성요소가 질서 정연한 구조를 이룸) 현상을 연구하는데 있어서 약물전달 및 나노입자 제조에 쓰이는 리포좀 구조 형성이 중요한 모델로 취급되고 있다.Recently, thanks to the development of nanotechnology, research on the properties or control of individual liposomes has been actively conducted. Liposomes are a drug delivery medium that is easy to mass produce and quality control, can be administered through various routes, can be administered repeatedly since there is no immune response, and is easy to change in structure and composition, so there is endless room for development. In addition, it is used in drug delivery and nanoparticle production to study the phenomenon of self-assembly (where molecules spontaneously form an ordered structure without artificial manipulation), which is attracting attention as a microprocessing tool in nanotechnology. Liposome structure formation is treated as an important model.
이 단계는 난용성 대마성분을 리포좀화하여 피부 내측으로 침투시킴으로써 피부외층 및 각질층을 통과한 대마성분이 피부 내측에 올바른 효과를 발휘하도록 하기 위함이다. This step is to liposome the poorly soluble hemp ingredients and allow them to penetrate into the inner skin so that the hemp ingredients that have passed through the outer skin layer and the stratum corneum have the correct effect on the inner skin.
화장품 조성물의 제형에 따라, 다양한 성분들이 함께 리포좀화되도록 한다. 바람직하게, 대마줄기 추출물 0.001 내지 20 중량부, 대마뿌리 추출물 0.001 내지 20 중량부, 바실러스/락토바실러스/대마뿌리발효 추출물 0.001 내지 20 중량부 및 대마씨오일 0.001 내지 20 중량부를 포함시켜 리포좀화한다. 바람직하게, 40~55℃에서 교반 및/또는 초음파를 이용하며 리포좀화한다. 단계별로 온도, 교반 및 초음파를 선택 조합하여 리포좀화할 수 있다.Depending on the formulation of the cosmetic composition, various ingredients are liposomed together. Preferably, 0.001 to 20 parts by weight of hemp stem extract, 0.001 to 20 parts by weight of hemp root extract, 0.001 to 20 parts by weight of Bacillus/Lactobacillus/hemp root fermentation extract, and 0.001 to 20 parts by weight of hemp seed oil are included to liposome. Preferably, liposomeization is performed using stirring and/or ultrasound at 40 to 55°C. Liposomeization can be achieved by selectively combining temperature, stirring, and ultrasound in each step.
5 단계) 방부제 및 향 등의 성분을 추가하여 화장품 조성물을 완성한다.Step 5) Complete the cosmetic composition by adding ingredients such as preservatives and fragrance.
실시예 2. 액상류 대마 복합물 리포좀 화장품 조성물Example 2. Liquid cannabis complex liposome cosmetic composition
실시예 1에 따른 대마 복합물을 리포좀 적용한 화장품 조성물 중 액상류로 토너, 앰플 등은 하기의 [표 1]에 표기된 조성을 가지도록 구성될 수 있다. Among the cosmetic compositions in which the hemp complex according to Example 1 was applied with liposomes, liquid toners, ampoules, etc. may be composed to have the compositions shown in [Table 1] below.
리포좀 공정
liposome process
실시예 3. 유액류 대마 복합물 리포좀 화장품 조성물Example 3. Emulsion-like hemp complex liposome cosmetic composition
실시예 1에 따른 대마 복합물을 리포좀 적용한 화장품 조성물 중 유액류로 에멀젼, 세럼, 크림 등은 하기의 [표 2]에 표기된 조성을 가지도록 구성될 수 있다. Among the cosmetic compositions in which the hemp complex according to Example 1 was applied with liposomes, emulsions, serums, creams, etc. may be composed to have the compositions shown in Table 2 below.
리포좀 공정
liposome process
실시예 4. 기타 대마 복합물 리포좀 화장품 조성물Example 4. Other hemp complex liposome cosmetic compositions
본 발명의 화장품 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 팩, 마사지크림 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The cosmetic composition of the present invention can be prepared in any formulation conventionally prepared in the art, for example, solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing products. , oil, powder foundation, emulsion foundation, wax foundation, pack, massage cream and spray, etc., but is not limited thereto. More specifically, it can be manufactured in the form of softening lotion, nourishing lotion, nourishing cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray, or powder.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier ingredient. You can.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizing agent or emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol, or fatty acid ester of sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소 결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, the carrier ingredients include water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, and polyoxyethylene sorbitan ester, and microcrystals. Cellulose, aluminum metahydroxide, bentonite, agar, or tracant may be used.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로 플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, or polyamide powder can be used as the carrier component. In particular, when the formulation is a spray, chlorofluorohydrocarbon and propane may be used as carrier ingredients. /May contain propellants such as butane or dimethyl ether.
본 발명의 제형이 계면활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄 올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing agent, the carrier ingredients include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, and fatty acid amide ether. Sulfates, alkylamidobetaines, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives, or ethoxylated glycerol fatty acid esters may be used.
본 발명의 화장품 조성물이 비누, 계면활성제 함유 클렌징 제형 또는 계면활성제 비함유 클렌징 제형일 경우, 피부에 도포한 후 닦아내거나 떼거나 물로 씻어낼 수도 있다. 구체적인 예로서, 상기 비누는 액상비누, 가루비누, 고형비누 및 오일비누이며, 상기 계면활성제 함유 클렌징 제형은 클렌징 폼, 클렌징 워터, 클렌징 수건 및 클렌징 팩이며, 상기 계면활성제 비 함유 클렌징 제형은 클렌징크림, 클렌징 로션, 클렌징 워터 및 클렌징 겔이며, 이에 한정되는 것은 아니다.When the cosmetic composition of the present invention is a soap, a surfactant-containing cleansing formulation, or a surfactant-free cleansing formulation, it can be applied to the skin and then wiped off, removed, or washed with water. As a specific example, the soap is liquid soap, powdered soap, solid soap, and oil soap, the surfactant-containing cleansing formulation is cleansing foam, cleansing water, cleansing towel, and cleansing pack, and the surfactant-free cleansing formulation is cleansing cream. , cleansing lotion, cleansing water and cleansing gel, but are not limited thereto.
지금까지 본 발명에 대하여 바람직한 실시예를 중심으로 살펴보았다.So far, the present invention has been examined with a focus on preferred embodiments.
본 명세서에 기재된 실시예와 도면에 도시된 구성은 본 발명의 가장 바람직한 하나의 실시예에 관련된 것이고, 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 이들을 대체할 수 있는 다양한 균등물과 변형된 예들이 있을 수 있음을 이해하여야 한다.The embodiments described in this specification and the configurations shown in the drawings are related to one of the most preferred embodiments of the present invention, and do not represent the entire technical idea of the present invention, so various equivalents and modifications that can replace them are provided. It should be understood that there may be examples.
따라서 본 발명은 제시되는 실시예에 한정되지 않으며, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의하여 본 발명의 기술 사상과 아래에 기재될 특허청구범위에 기재된 기술사상의 균등한 범위 내에서 다양한 수정 및 변경이 가능한 실시예가 있을 수 있다.Therefore, the present invention is not limited to the presented embodiments, and is within the equivalent scope of the technical idea of the present invention and the technical idea described in the patent claims below, as can be understood by those skilled in the art to which the present invention pertains. There may be embodiments in which various modifications and changes are possible.
Claims (5)
피부보호제 하이드롤라이즈드콜라겐추출물 0.001~20 중량부, 보습제 글리세린 0.1~10 중량부, 피부컨디셔닝제 나이아신아마이드 2~5 중량부, 피부컨디셔닝제 알란토인 0.01~0.5 중량부, 피부컨디셔닝제 아데노신 0.04 중량부, 보습제 부틸렌글라이콜 0.1~10 중량부, 계면활성제 하이드로제네이티드레시틴 0.5~2 중량부, 피부컨디셔닝제 메틸트라이메티콘 0.1~10 중량부, 피부컨디셔닝제 해바라기씨오일 0.1~10 중량부, 피부컨디셔닝제 글리세레스-25피씨에이아이소스테아레이트 0.1~3 중량부, 피부컨디셔닝제 트라이메틸펜탄다이올/아디픽애씨드코폴리머 0.1~3 중량부 및 항산화제 토코페롤 0.001~1 중량부를 혼합한 후 리포좀으로 제조하고,
상기 리포좀에 용제 다이프로필렌글라이콜 0.1~10 중량부, 방부제, 향 다마스크장미꽃오일 0.001~2 중량부를 첨가하여 제조된 조성물인 것을 특징으로 하는, 대마 복합물의 리포좀을 포함하는 화장품 조성물.A hemp complex consisting of 0.001 to 20 parts by weight of hemp root extract, 0.001 to 20 parts by weight of hemp stem extract, 0.001 to 20 parts by weight of hemp root fermentation extract, and 0.001 to 20 parts by weight of hemp seed oil,
Skin protectant hydrolyzed collagen extract 0.001~20 parts by weight, moisturizer glycerin 0.1~10 parts by weight, skin conditioning agent niacinamide 2~5 parts by weight, skin conditioning agent allantoin 0.01~0.5 parts by weight, skin conditioning agent adenosine 0.04 parts by weight , humectant butylene glycol 0.1 to 10 parts by weight, surfactant hydrogenated lecithin 0.5 to 2 parts by weight, skin conditioning agent methyl trimethicone 0.1 to 10 parts by weight, skin conditioning agent sunflower seed oil 0.1 to 10 parts by weight, skin Mix 0.1 to 3 parts by weight of conditioning agent Glycereth-25PCA isostearate, 0.1 to 3 parts by weight of skin conditioning agent trimethylpentanediol/adipic acid copolymer, and 0.001 to 1 part by weight of antioxidant tocopherol, then form into liposomes. manufacturing,
A cosmetic composition containing a liposome of a hemp complex, characterized in that it is a composition prepared by adding 0.1 to 10 parts by weight of solvent dipropylene glycol, a preservative, and 0.001 to 2 parts by weight of fragrant damask rose flower oil to the liposome.
피부보호제 하이드롤라이즈드콜라겐추출물 0.001~20 중량부, 보습제 글리세린 0.1~10 중량부, 피부컨디셔닝제 나이아신아마이드 2~5 중량부, 피부컨디셔닝제 알란토인 0.01~0.5 중량부, 피부컨디셔닝제 아데노신 0.04 중량부, 계면활성제 하이드로제네이티드레시틴 0.5~2 중량부, 피부컨디셔닝제 메틸트라이메티콘 0.1~10 중량부, 피부컨디셔닝제 해바라기씨오일 0.1~10 중량부, 피부컨디셔닝제 글리세레스-25피씨에이아이소스테아레이트 0.1~3 중량부, 피부컨디셔닝제 트라이메틸펜탄다이올/아디픽애씨드코폴리머 0.1~3 중량부, 항산화제 토코페롤 0.001~1 중량부, 피부컨디셔닝제 폴리글리세릴-3메틸글루코오스다이스테아레이트 0.1~3 중량부, 피부컨디셔닝제 폴리글리세릴-2스테아레이트 0.1~3 중량부, 유화제 글리세릴스테아레이트 0.1~3 중량부, 유화안정제 스테아릴알코올 0.1~3 중량부, 피부컨디셔닝제 호호바씨오일 0.1~10 중량부, 계면활성제 세테아릴글루코사이드 0.1~3 중량부, 계면활성제 솔비탄올리베이트 0.1~3 중량부 및 유화안정제 세테아릴알코올 0.1~3 중량부를 혼합한 후 리포좀으로 제조하고,
상기 리포좀에 점증제 아크릴레이트/C10-30알킬아크릴레이트크로스폴리머 0.1~0.5 중량부, 용제 다이프로필렌글라이콜 0.1~10 중량부, 방부제, 향 다마스크장미꽃오일 0.001~2 중량부를 첨가하여 제조된 조성물인 것을 특징으로 하는, 대마 복합물의 리포좀을 포함하는 화장품 조성물.A hemp complex consisting of 0.001 to 20 parts by weight of hemp root extract, 0.001 to 20 parts by weight of hemp stem extract, 0.001 to 20 parts by weight of hemp root fermentation extract, and 0.001 to 20 parts by weight of hemp seed oil,
Skin protectant hydrolyzed collagen extract 0.001~20 parts by weight, moisturizer glycerin 0.1~10 parts by weight, skin conditioning agent niacinamide 2~5 parts by weight, skin conditioning agent allantoin 0.01~0.5 parts by weight, skin conditioning agent adenosine 0.04 parts by weight , surfactant hydrogenated lecithin 0.5~2 parts by weight, skin conditioning agent methyl trimethicone 0.1~10 parts by weight, skin conditioning agent sunflower seed oil 0.1~10 parts by weight, skin conditioning agent Glycereth-25PCA isostearate 0.1~3 parts by weight, skin conditioning agent trimethylpentanediol/adipic acid copolymer 0.1~3 parts by weight, antioxidant tocopherol 0.001~1 part by weight, skin conditioning agent polyglyceryl-3methylglucose distearate 0.1~ 3 parts by weight, skin conditioning agent polyglyceryl-2 stearate 0.1~3 parts by weight, emulsifier glyceryl stearate 0.1~3 parts by weight, emulsion stabilizer stearyl alcohol 0.1~3 parts by weight, skin conditioning agent jojoba seed oil 0.1~ Prepare liposomes by mixing 10 parts by weight, 0.1 to 3 parts by weight of surfactant cetearyl glucoside, 0.1 to 3 parts by weight of surfactant sorbitan olivate, and 0.1 to 3 parts by weight of emulsion stabilizer cetearyl alcohol,
Prepared by adding 0.1 to 0.5 parts by weight of thickener acrylate/C10-30 alkyl acrylate crosspolymer, 0.1 to 10 parts by weight of solvent dipropylene glycol, preservative, and 0.001 to 2 parts by weight of fragrance damask rose flower oil to the liposome. A cosmetic composition containing liposomes of a hemp complex, characterized in that it is a composition made of hemp.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230035208A KR102594005B1 (en) | 2023-03-17 | 2023-03-17 | Cosmetic composition comprising cannabis liposome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230035208A KR102594005B1 (en) | 2023-03-17 | 2023-03-17 | Cosmetic composition comprising cannabis liposome |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102594005B1 true KR102594005B1 (en) | 2023-10-26 |
Family
ID=88508787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020230035208A KR102594005B1 (en) | 2023-03-17 | 2023-03-17 | Cosmetic composition comprising cannabis liposome |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102594005B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190098648A (en) | 2018-02-14 | 2019-08-22 | (주)카이언바이오텍 | Cosmetic composition containing cannabidiol or its derivative for improving atopic dermatitis |
KR20220049714A (en) | 2020-10-15 | 2022-04-22 | 바이오랩코리아 주식회사 | Cosmetic Composition For Improving Skin Whitening and Anti-wrinkling Comprising Extract Of Cannabis |
KR20220091957A (en) | 2020-12-24 | 2022-07-01 | 건국대학교 글로컬산학협력단 | Composition for anti-aging, anti-inflammation or skin regeneration containing Cannabis sativa stem extract as effective component |
-
2023
- 2023-03-17 KR KR1020230035208A patent/KR102594005B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190098648A (en) | 2018-02-14 | 2019-08-22 | (주)카이언바이오텍 | Cosmetic composition containing cannabidiol or its derivative for improving atopic dermatitis |
KR20220049714A (en) | 2020-10-15 | 2022-04-22 | 바이오랩코리아 주식회사 | Cosmetic Composition For Improving Skin Whitening and Anti-wrinkling Comprising Extract Of Cannabis |
KR20220091957A (en) | 2020-12-24 | 2022-07-01 | 건국대학교 글로컬산학협력단 | Composition for anti-aging, anti-inflammation or skin regeneration containing Cannabis sativa stem extract as effective component |
Non-Patent Citations (4)
Title |
---|
"대마 (Cannabis sativa L.) 뿌리의 주요 페놀 성분으로서 파라-쿠마르산과 에틸 파라-쿠마레이트의 동정" (오창민, 경북대학교 대학원, 2022) |
Lima, K.S.B., et al., Cannabis roots: Pharmacological and toxicological studies in mice. Journal of Ethnopharmacology, 2021. 271: p. 113868 |
Menezes, P.M.N., et al., Chemical Analysis by LC-MS of Cannabis sativa Root Samples from Northeast Brazil and Evaluation of Antitussive and Expectorant Activities. Planta Medica, 2021.) |
The Journal of the Convergence on Culture Technology, 2021, 제7권, 제4호, 페이지 683-691* * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0761915A (en) | External agent for skin | |
JP2019535783A (en) | Composition comprising truffle extract and neohesperidin dihydrochalcone | |
KR20180107438A (en) | Cosmetic composition for skin regeneration comprising Ainsliaea acerifolia extract or its fraction as effective component | |
JP3787566B2 (en) | Cosmetic composition for caring for male skin and hair | |
KR102428341B1 (en) | Composition for the natural surfactant and cosmetic composition containing Saponaria officinalis, Yucca Schidigera and Quillaia saponaria MOLINA | |
JP2011088845A (en) | Involucrin expression inhibitor | |
KR102221033B1 (en) | Cosmetic composition for moisturizing skin comprising mixed extracts of papaver rhoeas, red clover, cimicifuga racemosa and andrographis paniculata | |
JP2020193198A (en) | Fermented extract of aerial parts of bitter orange | |
KR101142010B1 (en) | Cosmetic composition Comprising Moisture Quality Component As Active Ingredient | |
KR101542176B1 (en) | The high functional cosmetic composition comprising orostachys japonicus extract or orostachys japonicus callus culture extracts | |
KR101862039B1 (en) | A cosmetic composition containing spicule powder and natural complex extract stabilized in nanoliposome | |
KR102335683B1 (en) | Cosmetic composition for alleviating acne comprising rosa rugosa extract and salvia plebeia extract | |
FR2928090A1 (en) | USE OF AN EXTRACT OF ORCHID VANDA COERULEA AS A MOISTURIZING AGENT FOR THE SKIN | |
KR102594005B1 (en) | Cosmetic composition comprising cannabis liposome | |
KR20210135034A (en) | Composition for improving skin barrier comprising herb extracts mixture | |
TR202008828A2 (en) | METHOD OF OBTAINING HIPPOPHAE RHAMNOIDES EXTRACT ENCAPSULATED WITH LIPOSOMAL TECHNOLOGY FOR USE IN COSMETIC FORMULAS | |
CN108135823A (en) | Anti-aging comprising carnosine, soybean peptide and Andrographis Paniculata uses composition | |
KR20200059446A (en) | Cosmetic composition comprising the extract of fermented Sprout leaf/stem ginseng for skin anti-wrinkle effect and producing method thereof | |
KR102224631B1 (en) | Cosmetic composition containing the rehmannia root extract | |
KR102107193B1 (en) | Cosmetic composition comprising extract of calendula arvensis fermented by aureobasidium pullulans | |
KR102121457B1 (en) | Cosmetic composition comprising the extract of fermented Sophora Japonica Fruits for skin anti-wrinkle effect and producing method thereof | |
KR101901133B1 (en) | Cosmetic composition for skin anti-wrinkle comprising Heracleum moellendorffii extract as effective component | |
KR101871577B1 (en) | Anti-aging cosmetic composition containing alpine area plant-derived rosemary oil | |
KR102555418B1 (en) | Cosmetic composition for protecting skin comprising mixed extracts of androgrphis paniculta and selaginella tamaricina fermanated by bacillus subtillus j2k-351 strain | |
KR20190050415A (en) | Cosmetic composition containing extract of fraxinus rhynchophylla for improving skin wrinkle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |